
Claro Pharmaceuticals Private Limited
About Claro Pharmaceuticals Private Limited
Data last updated:
Claro Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 28 March 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2011PTC073540. Its GSTIN is 36AAECC4747M1ZA (Telangana).
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Chevuru Hariprasad and Arun Singh.
Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at 16 – 2 – 753/1/192 Konark Towers Flat No. 405 Gaddi Annaram, Hyderabad, Telangana, India – 500035.
As per the financials filed for FY 2020, the company reported a revenue of ₹37.41 Lakh, a growth of 5% compared to the previous year. For the same year it recorded a net loss of ₹5,616 (net margin -0.2%) and EBITDA of ₹24,928 (EBITDA margin 0.7%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 7% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Claro Pharmaceuticals has one previous CIN (Corporate Identification Number): U24232AP2011PTC073540. The current CIN is U24232TG2011PTC073540, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2011PTC073540 | Current |
| U24232AP2011PTC073540 | Previous |
Contact details
Claro Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address16 – 2 – 753/1/192 Konark Towers Flat No. 405 Gaddi Annaram, Hyderabad, Telangana, India – 500035
- IndustryHealthcare, Medical & Laboratory Equipment
To see the full contact details of Claro Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Claro Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Claro Pharmaceuticals Private Limited, buy the company report.
Financials of Claro Pharmaceuticals Private Limited
FY 2020 filings availableClaro Pharmaceuticals Private Limited reported revenue of ₹37.41 Lakh (up 5% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 7% over five years, including 5% growth in the latest year. EBITDA fell 68% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹37.41 Lakh | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹24,928 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹5,616 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.7% | ||||
| Net Profit Margin | -0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Claro Pharmaceuticals Private Limited, buy the company report.
Board of directors of Claro Pharmaceuticals Private Limited
Claro Pharmaceuticals has 3 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arun Singh Also directs: Arsa Life Care Private Limited | Additional Director | 21 Mar 2022 | 4 Years 8 Months | Current |
| Chevuru Komaleswari | Additional Director | 09 Jan 2014 | 12 Years 10 Months | Current |
| Chevuru Hariprasad | Director | 16 Jul 2014 | 12 Years 4 Months | Current |
Auditor
Claro Pharmaceuticals Private Limited is audited by MANORANJAN REDDY AND ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MANORANJAN REDDY AND ASSOCIATES | FY 2019 | 018057S |
Shareholding
The shareholding of Claro Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Claro Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Claro Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Claro Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Claro Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAECC4747M1ZA | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Claro Pharmaceuticals Private Limited, buy the company report.
Recent activity
Claro Pharmaceuticals Private Limited has 11 board changes on record since 2014: 3 appointments and 8 cessations. The latest: Arun Singh was appointed as Additional Director on 21 Mar 2022.
2 earlier events are in the company report.
Frequently asked questions
Claro Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 28 March 2011 (15+ years old) and is registered under CIN U24232TG2011PTC073540.
Claro Pharmaceuticals has 3 current directors:
- Arun Singh - Additional Director
- Chevuru Komaleswari - Additional Director
- Chevuru Hariprasad - Director
The latest financial statements of Claro Pharmaceuticals on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 31 December 2020. Year-wise statements from 2015 are in the company report.
The GSTIN of Claro Pharmaceuticals is 36AAECC4747M1ZA, registered in Telangana.
The CIN (Corporate Identification Number) of Claro Pharmaceuticals is U24232TG2011PTC073540. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Claro Pharmaceuticals was incorporated on 28 March 2011, making it 15+ years old. It is registered with the Registrar of Companies, Hyderabad.
Arun Singh was appointed as Additional Director on 21 Mar 2022. Madana Mohan Reddy Ketham ceased to be Director on 21 Mar 2022. Rafayathunnisa Sunar ceased to be Director on 21 Mar 2022. Claro Pharmaceuticals has 11 board changes on record in total.
The registered office of Claro Pharmaceuticals is at 16 – 2 – 7531192 Konark Towers Flat No. 405 Gaddi Annaram, Hyderabad, Telangana, India – 500035.
Claro Pharmaceuticals operates in the healthcare industry, in the medical and laboratory equipment segment.
The compliance status of Claro Pharmaceuticals is compliant as of 12 September 2026. The company is actively filing with the Registrar of Companies.

